trial

Influence of Environmental Factors and Schizophrenia

NCTId NCT03296384
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 600 (estimated)
Sponsored by Assistance Publique - Hôpitaux de Paris
Primary completion 2018-11
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
600 (estimated)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2014-03
Primary completion
2018-11
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Clinical and environmental evaluation

Sponsors

Assistance Publique - Hôpitaux de ParisLead Sponsor
Institut national d'étude démographique (INED)Collaborator
CPN (INSERM U894) CH Sainte-Anne - ParisCollaborator
Institut National de la Santé Et de la Recherche Médicale, FranceCollaborator
Fondation FondaMentalCollaborator
University Hospital, Clermont-FerrandCollaborator

Investigators

2
Franck Schürhoff, MD PhDPrincipal Investigator
Pierre-Michel Llorca, MD PhDPrincipal Investigator

Sites

1 total
Créteil, France

Facts & assertions

4 sourced
Enrollment
600
Phase
NA
Primary Completion Date
2018-11
Status
UNKNOWN
relationships
The graph out of here
drug
Clinical and environmental evaluation
drug
lead_sponsor
Assistance Publique - Hôpitaux de Paris
company
collaborator
Institut national d'étude démographique (INED)
company
CPN (INSERM U894) CH Sainte-Anne - Paris
company
indication
Relatives
indication
Patients With Schizophrenia
indication
Schizophrenia
indication
investigator
Franck Schürhoff, MD PhD
person
Pierre-Michel Llorca, MD PhD
person